Pfizer Inc (PFE)

PFE on New York Consolidated

36.06USD
31 Jul 2015
Change (% chg)

-- (--)
Prev Close
$36.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,563,098
52-wk High
$36.46
52-wk Low
$27.51

PFE

Chart for PFE

About

Pfizer Inc. is a global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX,... (more)

Overall

Beta: 0.75
Market Cap(Mil.): $222,045.59
Shares Outstanding(Mil.): 6,157.67
Dividend: 0.28
Yield (%): 3.11

Financials

  PFE Industry Sector
P/E (TTM): 25.57 37.25 40.68
EPS (TTM): 1.41 -- --
ROI: -- 16.52 15.78
ROE: -- 17.30 16.82
Search Stocks

Wall Street ends sharply higher as China jitters ebb

- U.S. stocks ended sharply higher on Tuesday, breaking a five-day losing streak as attention shifted from trouble in Chinese equities to U.S. corporate earnings and to speculation the first Federal Reserve interest rate hike may not come until December.

28 Jul 2015

Pfizer's revenue, profit beat as vaccine sales rise

- Pfizer Inc on Tuesday reported better-than-expected second-quarter profit and revenue, helped by strong demand for its pneumonia vaccine and new breast cancer drug, sending its shares up 1 percent.

28 Jul 2015

UPDATE 2-Pfizer's revenue, profit beat as vaccine sales rise

July 28 - Pfizer Inc on Tuesday reported better-than-expected second-quarter profit and revenue, helped by strong demand for its pneumonia vaccine and new breast cancer drug, sending its shares up 1 percent.

28 Jul 2015

US STOCKS-Wall St set to open higher ahead of Fed meeting

* Futures up: Dow 71 pts, S&P 10 pts, Nasdaq 18 pts (Adds details, comment, updates prices)

28 Jul 2015

Pfizer revenue falls 7 percent

July 28 - U.S. drugmaker Pfizer Inc reported a 7 percent fall in quarterly revenue, hurt by a strong dollar.

28 Jul 2015

Lilly continues test of HDL cholesterol drug, on panel's advice

- Eli Lilly and Co on Monday said it would continue a large study of its high-profile experimental drug to raise "good" HDL cholesterol and lower "bad" LDL cholesterol, acting on the recommendation of a data monitoring committee.

27 Jul 2015

Lilly continues test of HDL cholesterol drug, on panel's advice

July 27 - Eli Lilly and Co on Monday said it would continue a large study of its high-profile experimental drug to raise "good" HDL cholesterol and lower "bad" LDL cholesterol, acting on the recommendation of a data monitoring committee.

27 Jul 2015

EU mergers and takeovers (July 24)

BRUSSELS, July 24 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

24 Jul 2015

REFILE-BRIEF-Pfizer's Indian unit intends to close Navi Mumbai plant

July 15 - Pfizer Ltd : * Intimated the concerned authorities that it intends to effect closure of its plant situated at thane belapur road, navi Mumbai * Decision To close the plant is based on an assessment of its long term viability and its ability to achieve the needed production * Closure will not impact the supply of any of the company's medicines to patients * There has practically been no production activity at this plant since 2013 * Source text: http://bit.ly/1f2pgRU * F

15 Jul 2015

US FDA bans Emcure Pharma's India plant over manufacturing issues

MUMBAI - The U.S. Food and Drug Administration has banned drug imports from an India manufacturing unit of Emcure Pharmaceuticals Ltd over violations of standard manufacturing practices, the latest in a series of Indian firms to face such action.

14 Jul 2015

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $100.21 +0.37
Novartis AG (NOVN.VX) CHF101.00 +0.60
Merck & Co., Inc. (MRK.N) $58.96 +0.44
Roche Holding Ltd. (ROG.VX) CHF280.80 +1.70
Abbott Laboratories (ABT.N) $50.69 -0.08
Bayer AG (BAYGn.DE) €133.95 -0.35
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €98.54 +0.57
AstraZeneca plc (AZN.L) 4,321.50p +1.50
GlaxoSmithKline plc (GSK.L) 1,398.00p +2.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$49.00
Provider : Wright Reports
$75.00
Provider : Stock Traders Daily
$20.00
Provider : S&P Capital IQ – STARS Reports
$127.00
Provider : Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks